Skip to content
Home/Companies/Biotech/Zymvol
Zymvol

Zymvol

Biotech·Spain·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Zymvol?

Zymvol is a Spanish Biotech company, currently owned by Elaia Partners since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elaia Partners
Investor
Elaia Partners
DTS3 · 2024 · VC

Key facts

HQSpain
SectorBiotech
Websitezymvol.com

More from DTS3

Other portfolio companies in the same fund.

Enodia Therapeutics
Enodia Therapeutics
Active
BiotechFrance· 2026
GetVocal AI
Active
AI/MLFrance· 2025
Mimic Robotics
Active
IndustrialsUS· 2025
Proxima Fusion
Proxima Fusion
Active
ClimateTechGermany· 2025
Streambased
Active
Data & AnalyticsUK· 2025
Biophta
Biophta
Active
BiotechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Zymvol?

Zymvol is currently owned by Elaia Partners, through DTS3, since 2023.

When did Elaia Partners acquire Zymvol?

Elaia Partners acquired Zymvol in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue